Australia’s UDI System Phases In: The TGA Compliance Timeline

Australia’s Unique Device Identification (UDI) system is moving from preparation to obligation. The Therapeutic Goods Administration (TGA) has set out, in detailed guidance, exactly when each class of medical device and IVD must comply, and the first hard deadline is now close. For manufacturers and sponsors supplying the Australian market, the planning needs to be happening now.

The Framework

The UDI regulatory framework came into effect on 24 March 2025, with amendments to the Therapeutic Goods Act 1989 and the Therapeutic Goods (Medical Devices) Regulations 2002. The Australian UDI Database (AusUDID) went live at the same time, opening a voluntary period in which sponsors can prepare labels, allocate UDI-DIs and test their data submission methods ahead of their mandatory date.

The system is being introduced over five years, high-risk devices first, with full compliance from 1 July 2030. There are two compliance milestones for each device class: first, applying the UDI Carrier to labels and packaging and submitting UDI records to the AusUDID, and second, direct marking of reusable devices and submitting that information. UDI records must be submitted within 30 days of a device next being supplied in Australia.

The Key Compliance Start Dates

For medical devices, the first milestone (labelling and UDI record submission) falls as follows:

Device classUDI compliance start date
Class III1 July 2026
Class IIb1 July 2026
Class IIa1 July 2027
Class Is1 July 2028

For IVDs, the dates run later: Class 4 and Class 3 IVDs from 1 July 2028, and Class 2 and Class 1 IVDs from 1 July 2029.

Direct marking obligations follow separately, starting 1 January 2028 for Class III devices and 1 January 2029 for most other classes.

The EU Connection

The detail most relevant to manufacturers already navigating Europe is that the TGA has deliberately aligned its transitional arrangements with the EU’s MDD to MDR transition. Because devices still supplied under an extended EU MDD certificate will not be UDI compliant in Europe until they become MDR compliant, the TGA grants matching extensions in Australia.

In practice, a Class III device supplied in Australia under an EU MDD certificate has until 1 January 2028 to meet UDI requirements, rather than the standard 1 July 2026. Class IIb implantables under MDD certificates also move to 1 January 2028, and Class IIb non-implantables, Class IIa and Class Is devices to 1 January 2029. Devices supplied under an EU MDR certificate, by contrast, must meet the standard Australian start dates. If an MDD device transitions to MDR certification before its extended Australian date, the obligation kicks in at the point of transition.

Existing Stock

The TGA has limited the burden of relabelling existing inventory. Only Class III and Class IIb devices manufactured and labelled before their compliance date, and still within the sponsor’s control on or after 1 July 2029, must be relabelled and have a UDI record submitted. “Within the sponsor’s control” means stock that has left the manufacturer but has not yet been supplied or distributed. Once a device has been supplied to a distributor, hospital or patient, it is exempt for its lifetime, and all other device classes are exempt entirely for existing stock.

Why It Matters

UDI compliance forms part of the Essential Principles, so failure to comply is not a paperwork footnote. The TGA can suspend or cancel a device’s inclusion in the Australian Register of Therapeutic Goods, apply civil penalties, or issue infringement notices. Where a sponsor genuinely cannot comply by the start date, a Consent to Supply application is possible, but the TGA treats these as exceptional and decides each on its merits before supply can continue.

For any manufacturer selling into Australia, the message from this guidance is to map your portfolio against these dates now, particularly the interaction between your EU certificate status and your Australian deadline, since that is where the timing is least intuitive.

If you would like help working out how your EU certificate position shapes your Australian UDI obligations, that is the kind of cross-market question Specculo helps manufacturers untangle. Get in touch if it would help.